252 related articles for article (PubMed ID: 15142844)
21. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.
Bulhak AA; Jung C; Ostenson CG; Lundberg JO; Sjöquist PO; Pernow J
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H719-27. PubMed ID: 19151258
[TBL] [Abstract][Full Text] [Related]
22. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
[TBL] [Abstract][Full Text] [Related]
23. The role of ATP sensitive K+ channels and of nitric oxide synthase on myocardial ischemia/reperfusion-induced apoptosis.
Gok S; Vatansever S; Vural K; Sekuri C; Izanli A; Tezcan A; Cilaker S
Acta Histochem; 2006; 108(2):95-104. PubMed ID: 16566960
[TBL] [Abstract][Full Text] [Related]
24. Role of protein kinase C in mitochondrial KATP channel-mediated protection against Ca2+ overload injury in rat myocardium.
Wang Y; Ashraf M
Circ Res; 1999 May; 84(10):1156-65. PubMed ID: 10347090
[TBL] [Abstract][Full Text] [Related]
25. Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt pathway.
Wolfrum S; Dendorfer A; Schutt M; Weidtmann B; Heep A; Tempel K; Klein HH; Dominiak P; Richardt G
J Cardiovasc Pharmacol; 2004 Sep; 44(3):348-55. PubMed ID: 15475833
[TBL] [Abstract][Full Text] [Related]
26. Early ischaemic preconditioning requires Akt- and PKA-mediated activation of eNOS via serine1176 phosphorylation.
Yang C; Talukder MA; Varadharaj S; Velayutham M; Zweier JL
Cardiovasc Res; 2013 Jan; 97(1):33-43. PubMed ID: 22977010
[TBL] [Abstract][Full Text] [Related]
27. Cardioprotective PKG-independent NO signaling at reperfusion.
Cohen MV; Yang XM; Liu Y; Solenkova NV; Downey JM
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H2028-36. PubMed ID: 20852051
[TBL] [Abstract][Full Text] [Related]
28. Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits.
Xuan YT; Tang XL; Qiu Y; Banerjee S; Takano H; Han H; Bolli R
Am J Physiol Heart Circ Physiol; 2000 Nov; 279(5):H2360-71. PubMed ID: 11045973
[TBL] [Abstract][Full Text] [Related]
29. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells.
Haynes MP; Sinha D; Russell KS; Collinge M; Fulton D; Morales-Ruiz M; Sessa WC; Bender JR
Circ Res; 2000 Oct; 87(8):677-82. PubMed ID: 11029403
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection.
Wolfrum S; Dendorfer A; Rikitake Y; Stalker TJ; Gong Y; Scalia R; Dominiak P; Liao JK
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1842-7. PubMed ID: 15319269
[TBL] [Abstract][Full Text] [Related]
31. AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets.
Fleming I; Schulz C; Fichtlscherer B; Kemp BE; Fisslthaler B; Busse R
Thromb Haemost; 2003 Nov; 90(5):863-71. PubMed ID: 14597982
[TBL] [Abstract][Full Text] [Related]
32. Vanadate is a potent activator of endothelial nitric-oxide synthase: evidence for the role of the serine/threonine kinase Akt and the 90-kDa heat shock protein.
Papapetropoulos A; Fulton D; Lin MI; Fontana J; McCabe TJ; Zoellner S; García-Cardeña G; Zhou Z; Gratton JP; Sessa WC
Mol Pharmacol; 2004 Feb; 65(2):407-15. PubMed ID: 14742683
[TBL] [Abstract][Full Text] [Related]
33. Estrogen receptor activation of phosphoinositide-3 kinase, akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects.
Stirone C; Boroujerdi A; Duckles SP; Krause DN
Mol Pharmacol; 2005 Jan; 67(1):105-13. PubMed ID: 15496504
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia increases Hsp90 binding to eNOS via PI3K-Akt in porcine coronary artery endothelium.
Chen JX; Meyrick B
Lab Invest; 2004 Feb; 84(2):182-90. PubMed ID: 14661033
[TBL] [Abstract][Full Text] [Related]
35. Acetylcholine and bradykinin trigger preconditioning in the heart through a pathway that includes Akt and NOS.
Krieg T; Qin Q; Philipp S; Alexeyev MF; Cohen MV; Downey JM
Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2606-11. PubMed ID: 15331366
[TBL] [Abstract][Full Text] [Related]
36. Propionyl-L-carnitine induces eNOS activation and nitric oxide synthesis in endothelial cells via PI3 and Akt kinases.
Ning WH; Zhao K
Vascul Pharmacol; 2013; 59(3-4):76-82. PubMed ID: 23850990
[TBL] [Abstract][Full Text] [Related]
37. Hepatocyte growth factor stimulates nitric oxide production through endothelial nitric oxide synthase activation by the phosphoinositide 3-kinase/Akt pathway and possibly by mitogen-activated protein kinase kinase in vascular endothelial cells.
Uruno A; Sugawara A; Kanatsuka H; Arima S; Taniyama Y; Kudo M; Takeuchi K; Ito S
Hypertens Res; 2004 Nov; 27(11):887-95. PubMed ID: 15824471
[TBL] [Abstract][Full Text] [Related]
38. Akt-dependent phosphorylation of serine 1179 and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide.
Cai H; Li Z; Davis ME; Kanner W; Harrison DG; Dudley SC
Mol Pharmacol; 2003 Feb; 63(2):325-31. PubMed ID: 12527803
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase.
Kanno S; Lee PC; Zhang Y; Ho C; Griffith BP; Shears LL; Billiar TR
Circulation; 2000 Jun; 101(23):2742-8. PubMed ID: 10851213
[TBL] [Abstract][Full Text] [Related]
40. Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide.
Babaei S; Teichert-Kuliszewska K; Zhang Q; Jones N; Dumont DJ; Stewart DJ
Am J Pathol; 2003 Jun; 162(6):1927-36. PubMed ID: 12759249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
